Exagen Inc — Quarterly Financial Statistics (NASDAQ:XGN) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Cash from operating activities 2.18 M-363 K10.67 M2.88 M-2.94 M 10.25 M Cash from investing activities 147 K146 K107 K209 K275 K 737 K Cash from financing activities 121 K216 K64 K21.8 M2.95 M 25.04 M Free cash flow 2.03 M-509 K10.56 M2.68 M-3.22 M 9.51 M

Haberler

Agilent Technologies (A) Lags Q1 Earnings and Revenue Estimates

3 ‘Strong Buy’ Stocks to Buy Now, 1/26/2026, According to Top Analysts - TipRanks.com

Canaccord Genuity maintains Buy rating on Exagen stock amid ASP challenges

KeyBanc, yaşam bilimleri araçları sektörünün 2026’da toparlanacağını vurguluyor

KeyBanc highlights life sciences tools sector recovery for 2026

Canaccord Genuity, Exagen hissesi için Al notunu tekrarlıyor ve 15 dolar hedefini koruyor

Canaccord Genuity reiterates Buy rating on Exagen stock, maintains $15 target

BTIG, Exagen’in güçlü büyümesi nedeniyle fiyat hedefini 13 dolardan 15 dolara yükseltti

Exagen stock price target raised to $15 from $13 at BTIG on strong growth

Exagen Inc. (XGN) Reports Q3 Loss, Tops Revenue Estimates

Booking Holdings To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Monday - Carpenter Technology (NYSE:CRS), Booking Holdings (NASDAQ:BKNG)

KeyBanc, gelişmiş geri ödeme sayesinde Exagen hisse fiyat hedefini 15 dolara yükseltti